Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era

Circulation

Volumn 113, Issue 20, 2006, Pages 2406-2412

  Hannan, Edward L ^a,k   Racz, Michael ^b   Holmes, David R ^c   King III, Spencer B ^d   Walford, Gary ^e   Ambrose, John A ^f   Sharma, Samin ^g   Katz, Stanley ^h   Clark, Luther T ⁱ   Jones, Robert H ^j  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d PIEDMONT HOSPITAL   (United States)

^e St Joseph's Hospital   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h North Shore Long Island Jewish Health System ^*  (United States)

ⁱ University Hospital of Brooklyn   (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY AT ALBANY   (United States)

more..

Author keywords

Angioplasty; Mortality; Percutaneous coronary intervention; Revascularization; Stents

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; COMORBIDITY; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; STENT; STROKE; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; STANDARD; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NEW YORK; RECURRENCE; RETROSPECTIVE STUDIES; STENTS; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33744468517     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.612267     Document Type: Article

References (25)

1. Schaff HV, Gersh BJ, Pluth JR, Danielson GK, Orszulak TA, Riga FJ, Piehler JM, Frye RL. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation. 1983;68(suppl II):200-204.
2. Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LA, Gibson C, Stewart RW, Taylor PC, Goormastic M. Determinants of 10-year survival after primary myocardial revascularization. Ann Surg. 1985;202:480-490.
3. Tyras DH, Kaiser GC, Barner HB, Pennington DG, Codd JE, William VL. Global left ventricular impairment and myocardial revascularization: determinants of survival. Ann Thorac Surg. 1984;37:47-51.
4. Bell MR, Gersh BJ, Schaff HV, Holmes DR Jr, Fisher LD, Alderman EL, Myers WO, Parsons LS, Reeder GS. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: a report from the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1992;86:446-457.
5. Buda AJ, Macdonald IL, Anderson MJ, Strauss HD, David TE, Berman ND. Long-term results following coronary bypass operation: importance of preoperative factors and complete revascularization. J Thorac Cardiovasc Surg. 1981;82:383-390.
6. Mariani G, De Servi S, Dellavalle A, Repetto S, Chierchia S, D'Urbano M, Repetto A, Klersy C, for the ROSAI Study Group. Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: are early and one-year results different? Cathet Cardiovasc Intervent. 2001;54:448-453.
7. Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM, for the Investigators of the NHLBI PTCA Registry. Long-term outcome of patients with incomplete vs. complete revascularization after multivessel PTCA: a report from the NHLBI Registry. Eur Heart J. 1998;19:103-111.
8. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PWI. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;19:559-564.
9. Bourassa MG, Kip KE, Jacobs AK, Jones RH, Sopko G, Rosen AD, Sharaf BL, Schwartz L, Chaitman BR, Alderman EL, Holmes DR, Roubin GS, Detre KM, Frye RL. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? J Am Coll Cardiol. 1999;33:1627-1636.
10. Nikolsky E, Gruberg L, Patil CV, Rougin A, Kapeliovich M, Petcherski S, Boulos M, Grenadier E, Amikam S, Markiewicz W, Beyar R. Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invasive Cardiol. 2004;16:102-106.
11. Faxon DP, Ghalilli K, Jacobs AK, Ruocco NA, Christellis EM, Kellett MA Jr, Varrichione TR, Ryan TJ. The degree of revascularization and outcome after multivessel coronary angioplasty. Am Heart J. 1992;123:854-859.
12. Cowley MJ, Vandormael M, Topol EJ, Whitlow PA, Dean LS, Bulle TM, Ellis SG. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? J Am Coll Cardiol. 1993;22:1289-1297.
13. Samson M, Meester HJ, de Feyter PJ, Strauss B, Serruys PW. Successful multiple segment coronary angioplasty: effect of completeness of revascularization in single-vessel multilesions and multivessels. Am Heart J. 1990;120:1-12.
14. Bell MR, Bailey KR, Reeder GS, Lapeyre AC, Holmes DR. Percutaneous transluminal angioplasty in patients with multivessel disease: how important is complete revascularization for cardiac-event free survival? J Am Coll Cardiol. 1990;16:553-562.
15. Vandormael MG, Chaitman BR, Ischinger T, Aker UT, Harper M, Hernandez J, Deligonul U, Kennedy HL. Immediate and short-term benefit of multi-lesion coronary angioplasty: influence of degree of revascularization. J Am Coll Cardiol. 1985;6:983-991.
16. Reeder GS, Holmes DR, Detre KM, Kostigan T, Kelsey SF. Degree of revascularization in patients with multivessel coronary disease: a report from the National Heart, Blood, and Lung Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1988;77:638-644.
17. Cantor AB. SAS Survival Analysis Techniques for Medical Research. 2nd ed. Cary, NC: SAS Institute Inc; 2003.
18. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD, Galbraith PD, Knudtson ML, for the APPROACH Investigators. Comparison of two methods for calculating adjusted survival curves from proportional hazards. JAMA. 2001;286:1494-1497.
19. Rosenbaum PR, Rubin DR. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
20. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
21. Lauer MS, Topol EJ. Clinical trials: multiple treatments, multiple end points, and multiple lessons. JAMA. 2003;289:2575-2577.
22. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA. Long-term outcomes of coronary-artery bypass graft surgery versus stent implantation. N Engl J Med. 2005;352:2174-2183.
23. Hannan EL, Racz MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW, Jones RH. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1999;33:63-72.
24. Jones RH, Kesler K, Phillips HR III, Mark DB, Smith PK, Nelson CL, Newman MF, Reves JG, Anderson RW, Califf RM. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996;111:1013-1025.
25. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293-1304.